Trial Profile
Solifenacin in a Flexible Dose Regimen With Tolterodine as an Active Comparator in a Double-Blind, Double-Dummy, Randomised Overactive Bladder Symptom Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2009
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms STAR
- Sponsors Astellas Pharma
- 09 Dec 2008 New trial record.